Minerva Neurosciences, Inc. (NERV)

2.32 +0.08 (+3.57%) USD  |  NASDAQ  |  Oct 30, 16:00
2.30 -0.02 (-0.86%) After-Hours: 20:00
More

Minerva Neurosciences Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for NERV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 14, 2026 --
August 10, 2026 --
August 07, 2026 --
May 18, 2026 --
May 11, 2026 --
May 05, 2026 --
April 15, 2026 --
March 12, 2026 --
Date Value
December 01, 2025 --
November 06, 2025 --
February 26, 2025 --
November 06, 2024 --
August 07, 2024 --
May 02, 2024 --
February 23, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Heron Therapeutics, Inc. Upgrade
Tonix Pharmaceuticals Holding Corp. Upgrade
Karyopharm Therapeutics, Inc. Upgrade
Corbus Pharmaceuticals Holdings, Inc. Upgrade
Ocugen, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade